Replies to post #173 on CytomX Therapeutics Inc (CTMX)

[TheFinalCD]

$CTMX learned the hard way , lost money on many Phase I stocks

MY ADVICE IS ITS BEST TO JUST STAY AWAY FROM MOST PHASE I STOCKS ALL TOGETHER

this ones news sounds weak

https://www.globenewswire.com/news-release/2024/05/08/2878255/37704/en/CytomX-Therapeutics-Announces-Positive-Initial-Phase-1a-Dose-Escalation-Data-for-Monotherapy-CX-904-EGFRxCD3-PROBODY-T-Cell-Engager.html

dose escalation?

$CTMX its CX-904, T-cell engager, only works for pancreatic cancer? It appears not effective for CRC, gastric, esophageal, NSCLC, HNSCC, why? forget this one. Be long $JANX and $LVTX

— Nick zheng (@pick1998_2) May 8, 2024

$CTMX Down 40%. You can celebrate two PRs though. 😂 https://t.co/OZLhxKdGrm

— Alp Bugra Basat, MD (@AlpBugraBasat) May 8, 2024